Publication: Clusterin Is Associated with Systemic and Synovial Inflammation in Knee Osteoarthritis
2
Issued Date
2020-01-01
Resource Type
ISSN
19476043
19476035
19476035
Other identifier(s)
2-s2.0-85090981519
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Cartilage. (2020)
Suggested Citation
Tachatra Ungsudechachai, Sittisak Honsawek, Jiraphun Jittikoon, Wanvisa Udomsinprasert Clusterin Is Associated with Systemic and Synovial Inflammation in Knee Osteoarthritis. Cartilage. (2020). doi:10.1177/1947603520958149 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/59081
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Clusterin Is Associated with Systemic and Synovial Inflammation in Knee Osteoarthritis
Other Contributor(s)
Abstract
© The Author(s) 2020. Objectives: This study aimed to determine possible associations between transcriptional and translational levels of clusterin (CLU) in the systemic and local joint environments with the severity of knee osteoarthritis (OA) and to investigate CLU mRNA expression in knee OA fibroblast-like synoviocytes (FLSs) stimulated with tumor necrosis factor-α. Design: Circulating and synovial fluid CLU levels in 259 knee OA patients were quantified using an enzyme-linked immunosorbent assay. Relative CLU mRNA expression in 50 knee OA synovial tissues and 4 knee OA FLSs was determined using real-time polymerase chain reaction. Results: Plasma CLU levels of knee OA patients were significantly higher than paired synovial fluid samples. Compared with early-stage knee OA patients, those with advanced-stage OA had considerably increased plasma and synovial fluid CLU levels. There were significant positive associations of plasma and synovial fluid CLU levels with radiographic severity of knee OA. Plasma CLU levels were directly correlated with its synovial fluid levels and high-sensitivity C-reactive protein levels in the patients. Receiver-operating characteristic curve analysis unveiled the potential utility of plasma CLU as a novel biomarker for knee OA severity (AUC = 0.80), with a sensitivity of 71.4% and a specificity of 73.3%. Marked upregulation of CLU mRNA expression was observed in both the inflamed synovial tissues and FLSs of knee OA. Conclusion: Increased CLU mRNA and protein levels in the systemic and local joint environments of knee OA might reflect knee OA severity, especially systemic and synovial inflammation.